{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:30:57Z","timestamp":1789133457360,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0410017"],"award-info":[{"award-number":["JP20fk0410017"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0410037"],"award-info":[{"award-number":["JP21fk0410037"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21ae0201007"],"award-info":[{"award-number":["JP21ae0201007"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20bm0804018"],"award-info":[{"award-number":["JP20bm0804018"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20am0401005"],"award-info":[{"award-number":["JP20am0401005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Access to Insights Basic Research Grant"},{"DOI":"10.13039\/501100006680","name":"Takeda Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006680","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SENSHIN Medical Research Foundation, Jichi Medical University Young Investigator Award,"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Base editing via CRISPR-Cas9 has garnered attention as a method for correcting disease-specific mutations without causing double-strand breaks, thereby avoiding large deletions and translocations in the host chromosome. However, its reliance on the protospacer adjacent motif (PAM) can limit its use. We aimed to restore a disease mutation in a patient with severe hemophilia B using base editing with SpCas9-NG, a modified Cas9 with the board PAM flexibility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We generated induced pluripotent stem cells (iPSCs) from a patient with hemophilia B (c.947T&gt;C; I316T) and established HEK293 cells and knock-in mice expressing the patient\u2019s\n                      <jats:italic>F9<\/jats:italic>\n                      cDNA. We transduced the cytidine base editor (C&gt;T), including the nickase version of Cas9 (wild-type SpCas9 or SpCas9-NG), into the HEK293 cells and knock-in mice through plasmid transfection and an adeno-associated virus vector, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Here we demonstrate the broad PAM flexibility of SpCas9-NG near the mutation site. The base-editing approach using SpCas9-NG but not wild-type SpCas9 successfully converts C to T at the mutation in the iPSCs. Gene-corrected iPSCs differentiate into hepatocyte-like cells in vitro and express substantial levels of\n                      <jats:italic>F9<\/jats:italic>\n                      mRNA after subrenal capsule transplantation into immunodeficient mice. Additionally, SpCas9-NG\u2013mediated base editing corrects the mutation in both HEK293 cells and knock-in mice, thereby restoring the production of the coagulation factor.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A base-editing approach utilizing the broad PAM flexibility of SpCas9-NG can provide a solution for the treatment of genetic diseases, including hemophilia B.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-023-00286-w","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T08:02:58Z","timestamp":1681891378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4054-6748","authenticated-orcid":false,"given":"Takafumi","family":"Hiramoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kashiwakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1869-2450","authenticated-orcid":false,"given":"Morisada","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3004-8457","authenticated-orcid":false,"given":"Nemekhbayar","family":"Baatartsogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Kamoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8424-4843","authenticated-orcid":false,"given":"Tomoyuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4373-5050","authenticated-orcid":false,"given":"Hiroshi","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishimasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8964-8609","authenticated-orcid":false,"given":"Hideki","family":"Uosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Hanazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1813-7008","authenticated-orcid":false,"given":"Osamu","family":"Nureki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5082-6394","authenticated-orcid":false,"given":"Tsukasa","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"286_CR1","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","volume":"344","author":"PM Mannucci","year":"2001","unstructured":"Mannucci, P. M. & Tuddenham, E. G. D. The hemophilias\u2014from royal genes to gene therapy. N. Engl. J. Med. 344, 1773\u20131779 (2001).","journal-title":"N. Engl. J. Med."},{"key":"286_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2988","volume":"12","author":"F Mingozzi","year":"2011","unstructured":"Mingozzi, F. & High, K. A. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet. 12, 341\u2013355 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"286_CR3","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1517\/21678707.2015.1069179","volume":"3","author":"VR Arruda","year":"2015","unstructured":"Arruda, V. R. & Samelson-Jones, B. J. Obstacles and future of gene therapy for hemophilia. Expert Opin. Orphan Drugs 3, 997\u20131010 (2015).","journal-title":"Expert Opin. Orphan Drugs"},{"key":"286_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04625-5","volume":"7","author":"T Ohmori","year":"2017","unstructured":"Ohmori, T. et al. CRISPR\/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice. Sci. Rep. 7, 4159 (2017).","journal-title":"Sci. Rep."},{"key":"286_CR5","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1182\/blood-2013-04-497354","volume":"122","author":"XM Anguela","year":"2013","unstructured":"Anguela, X. M. et al. Robust ZFN-mediated genome editing in adult hemophilic mice. Blood 122, 3283\u20133287 (2013).","journal-title":"Blood"},{"key":"286_CR6","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.dnarep.2008.06.018","volume":"7","author":"Z Mao","year":"2008","unstructured":"Mao, Z., Bozzella, M., Seluanov, A. & Gorbunova, V. Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair 7, 1765\u20131771 (2008).","journal-title":"DNA Repair"},{"key":"286_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"286_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765\u2013771 (2018).","journal-title":"Nat. Biotechnol."},{"key":"286_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02143-8","volume":"21","author":"C Bi","year":"2020","unstructured":"Bi, C. et al. Long-read individual-molecule sequencing reveals CRISPR-induced genetic heterogeneity in human ESCs. Genome Biol. 21, 213 (2020).","journal-title":"Genome Biol."},{"key":"286_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15464","volume":"8","author":"HY Shin","year":"2017","unstructured":"Shin, H. Y. et al. CRISPR\/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat. Commun. 8, 15464 (2017).","journal-title":"Nat. Commun."},{"key":"286_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09006-2","volume":"10","author":"G Cullot","year":"2019","unstructured":"Cullot, G. et al. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations. Nat. Commun. 10, 1136 (2019).","journal-title":"Nat. Commun."},{"key":"286_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"286_CR13","doi-asserted-by":"publisher","first-page":"aaf8729","DOI":"10.1126\/science.aaf8729","volume":"353","author":"K Nishida","year":"2016","unstructured":"Nishida, K. et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science 353, aaf8729 (2016).","journal-title":"Science"},{"key":"286_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"286_CR15","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41591-018-0184-6","volume":"24","author":"AC Rossidis","year":"2018","unstructured":"Rossidis, A. C. et al. In utero CRISPR-mediated therapeutic editing of metabolic genes. Nat. Med. 24, 1513\u20131518 (2018).","journal-title":"Nat. Med."},{"key":"286_CR16","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-018-0209-1","volume":"24","author":"L Villiger","year":"2018","unstructured":"Villiger, L. et al. Treatment of a metabolic liver disease by in vivo genome base editing in adult mice. Nat. Med. 24, 1519\u20131525 (2018).","journal-title":"Nat. Med."},{"key":"286_CR17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nbt.4148","volume":"36","author":"S-M Ryu","year":"2018","unstructured":"Ryu, S.-M. et al. Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. Nat. Biotechnol. 36, 536\u2013539 (2018).","journal-title":"Nat. Biotechnol."},{"key":"286_CR18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ymthe.2020.01.005","volume":"28","author":"CKW Lim","year":"2020","unstructured":"Lim, C. K. W. et al. Treatment of a mouse model of ALS by in vivo base editing. Mol. Ther. 28, 1177\u20131189 (2020).","journal-title":"Mol. Ther."},{"key":"286_CR19","doi-asserted-by":"publisher","first-page":"eaay9101","DOI":"10.1126\/scitranslmed.aay9101","volume":"12","author":"W-H Yeh","year":"2020","unstructured":"Yeh, W.-H. et al. In vivo base editing restores sensory transduction and transiently improves auditory function in a mouse model of recessive deafness. Sci. Transl. Med. 12, eaay9101 (2020).","journal-title":"Sci. Transl. Med."},{"key":"286_CR20","doi-asserted-by":"crossref","unstructured":"Chen, Y. et al. Development of highly efficient dual\u2010AAV split adenosine base editor for in vivo gene therapy. Small Methods 4, 2000309 (2020).","DOI":"10.1002\/smtd.202000309"},{"key":"286_CR21","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1126\/science.aas9129","volume":"361","author":"H Nishimasu","year":"2018","unstructured":"Nishimasu, H. et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361, 1259\u20131262 (2018).","journal-title":"Science"},{"key":"286_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep03594","volume":"4","author":"M Nakagawa","year":"2015","unstructured":"Nakagawa, M. et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci. Rep. 4, 3594 (2015).","journal-title":"Sci. Rep."},{"key":"286_CR23","doi-asserted-by":"publisher","first-page":"eaao4774","DOI":"10.1126\/sciadv.aao4774","volume":"3","author":"AC Komor","year":"2017","unstructured":"Komor, A. C. et al. Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity. Sci. Adv. 3, eaao4774 (2017).","journal-title":"Sci. Adv."},{"key":"286_CR24","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1073\/pnas.1217039110","volume":"110","author":"T Hiramoto","year":"2013","unstructured":"Hiramoto, T. et al. Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells. Proc. Natl Acad. Sci. USA 110, 3023\u20133028 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"286_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.23354","volume":"51","author":"K Si-Tayeb","year":"2010","unstructured":"Si-Tayeb, K. et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51, 297\u2013305 (2010).","journal-title":"Hepatology"},{"key":"286_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/0963689717751734","volume":"27","author":"R Okamoto","year":"2018","unstructured":"Okamoto, R. et al. Human iPS cell\u2013based liver-like tissue engineering at extrahepatic sites in mice as a new cell therapy for hemophilia B. Cell Transplant. 27, 299\u2013309 (2018).","journal-title":"Cell Transplant."},{"key":"286_CR27","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1093\/nar\/gkv601","volume":"43","author":"D-JJ Truong","year":"2015","unstructured":"Truong, D.-J. J. et al. Development of an intein-mediated split\u2013Cas9 system for gene therapy. Nucleic Acids Res. 43, 6450\u20136458 (2015).","journal-title":"Nucleic Acids Res."},{"key":"286_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187\u2013197 (2015).","journal-title":"Nat. Biotechnol."},{"key":"286_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-017-3746-y","volume":"18","author":"LJ Zhu","year":"2017","unstructured":"Zhu, L. J. et al. GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases. BMC Genomics 18, 379 (2017).","journal-title":"BMC Genomics"},{"key":"286_CR30","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.stemcr.2018.01.006","volume":"10","author":"R-R Zhang","year":"2018","unstructured":"Zhang, R.-R. et al. Human iPSC-derived posterior gut progenitors are expandable and capable of forming gut and liver organoids. Stem Cell Rep. 10, 780\u2013793 (2018).","journal-title":"Stem Cell Rep."},{"key":"286_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1598-0","volume":"574","author":"H Koike","year":"2019","unstructured":"Koike, H. et al. Modelling human hepato-biliary-pancreatic organogenesis from the foregut\u2013midgut boundary. Nature 574, 112\u2013116 (2019).","journal-title":"Nature"},{"key":"286_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/73187","volume":"6","author":"K Ohashi","year":"2000","unstructured":"Ohashi, K. et al. Sustained survival of human hepatocytes in mice: a model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat. Med. 6, 327\u2013331 (2000).","journal-title":"Nat. Med."},{"key":"286_CR33","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa0904377","volume":"361","author":"P Simioni","year":"2009","unstructured":"Simioni, P. et al. X-linked thrombophilia with a mutant factor IX (Factor IX Padua). N. Engl. J. Med. 361, 1671\u20131675 (2009).","journal-title":"N. Engl. J. Med."},{"key":"286_CR34","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42, D980\u2013D985 (2014).","journal-title":"Nucleic Acids Res."},{"key":"286_CR35","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum, M. J. et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 44, D862\u2013D868 (2016).","journal-title":"Nucleic Acids Res."},{"key":"286_CR36","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 19, 770\u2013788 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"286_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.blre.2016.08.003","volume":"31","author":"LL Swystun","year":"2017","unstructured":"Swystun, L. L. & James, P. D. Genetic diagnosis in hemophilia and von Willebrand disease. Blood Rev. 31, 47\u201356 (2017).","journal-title":"Blood Rev."},{"key":"286_CR38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1096\/fj.201901587R","volume":"34","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. Highly efficient base editing with expanded targeting scope using SpCas9\u2010NG in rabbits. FASEB J. 34, 588\u2013596 (2020).","journal-title":"FASEB J."},{"key":"286_CR39","doi-asserted-by":"crossref","unstructured":"Negishi, K. et al. An adenine base editor with expanded targeting scope using SpCas9\u2010NGv1 in rice. Plant Biotechnol. J. 17, 1476\u20131478 (2019).","DOI":"10.1111\/pbi.13120"},{"key":"286_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.stem.2020.01.019","volume":"26","author":"MH Geurts","year":"2020","unstructured":"Geurts, M. H. et al. CRISPR-based adenine editors correct nonsense mutations in a cystic fibrosis organoid biobank. Cell Stem Cell 26, 503\u2013510.e507 (2020).","journal-title":"Cell Stem Cell"},{"key":"286_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton, R. T., Christie, K. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science 368, 290\u2013296 (2020).","journal-title":"Science"},{"key":"286_CR42","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s41587-020-0573-5","volume":"38","author":"M Song","year":"2020","unstructured":"Song, M. et al. Sequence-specific prediction of the efficiencies of adenine and cytosine base editors. Nat. Biotechnol. 38, 1037\u20131043 (2020).","journal-title":"Nat. Biotechnol."},{"key":"286_CR43","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan, L. W. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat. Biotechnol. 36, 843\u2013846 (2018).","journal-title":"Nat. Biotechnol."},{"key":"286_CR44","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41587-019-0193-0","volume":"37","author":"BW Thuronyi","year":"2019","unstructured":"Thuronyi, B. W. et al. Continuous evolution of base editors with expanded target compatibility and improved activity. Nat. Biotechnol. 37, 1070\u20131079 (2019).","journal-title":"Nat. Biotechnol."},{"key":"286_CR45","doi-asserted-by":"crossref","unstructured":"Zhao, D. et al. Glycosylase base editors enable C-to-A and C-to-G base changes. Nat. Biotechnol. 39, 35\u201340 (2021).","DOI":"10.1038\/s41587-020-0592-2"},{"key":"286_CR46","doi-asserted-by":"crossref","unstructured":"Kurt, I. C. et al. CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells. Nat. Biotechnol. 39, 41\u201346 (2021).","DOI":"10.1038\/s41587-020-0609-x"},{"key":"286_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"286_CR48","doi-asserted-by":"publisher","first-page":"eaaz0051","DOI":"10.1126\/sciadv.aaz0051","volume":"6","author":"X Ling","year":"2020","unstructured":"Ling, X. et al. Improving the efficiency of precise genome editing with site-specific Cas9-oligonucleotide conjugates. Sci. Adv. 6, eaaz0051 (2020).","journal-title":"Sci. Adv."},{"key":"286_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1126\/science.aax9181","volume":"365","author":"J Strecker","year":"2019","unstructured":"Strecker, J. et al. RNA-guided DNA insertion with CRISPR-associated transposases. Science 365, 48\u201353 (2019).","journal-title":"Science"},{"key":"286_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41586-019-1323-z","volume":"571","author":"SE Klompe","year":"2019","unstructured":"Klompe, S. E., Vo, P. L. H., Halpin-Healy, T. S. & Sternberg, S. H. Transposon-encoded CRISPR\u2013Cas systems direct RNA-guided DNA integration. Nature 571, 219\u2013225 (2019).","journal-title":"Nature"},{"key":"286_CR51","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1111\/tri.14128","volume":"34","author":"HA Reza","year":"2021","unstructured":"Reza, H. A., Okabe, R. & Takebe, T. Organoid transplant approaches for the liver. Transpl. Int. 34, 2031\u20132045 (2021).","journal-title":"Transpl. Int."},{"key":"286_CR52","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/hep.31705","volume":"74","author":"E Luce","year":"2021","unstructured":"Luce, E., Messina, A., Duclos\u2010Vall\u00e9e, J. C. & Dubart\u2010Kupperschmitt, A. Advanced techniques and awaited clinical applications for human pluripotent stem cell differentiation into hepatocytes. Hepatology 74, 1101\u20131116 (2021).","journal-title":"Hepatology"},{"key":"286_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cels.2020.11.002","volume":"12","author":"JJ Velazquez","year":"2021","unstructured":"Velazquez, J. J. et al. Gene regulatory network analysis and engineering directs development and vascularization of multilineage human liver organoids. Cell Syst. 12, 41\u201355.e11 (2021).","journal-title":"Cell Syst."},{"key":"286_CR54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D. et al. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493\u2013502 (2021).","journal-title":"N. Engl. J. Med."},{"key":"286_CR55","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","volume":"593","author":"K Musunuru","year":"2021","unstructured":"Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429\u2013434 (2021).","journal-title":"Nature"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00286-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00286-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00286-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T09:16:24Z","timestamp":1681895784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00286-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["286"],"URL":"https:\/\/doi.org\/10.1038\/s43856-023-00286-w","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.O. received grant support from Novo Nordisk (<i>The Access to Insights<\/i> Basic Research Grant). No competing interest exists for the remaining authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}